Flexjet Advances European Expansion with Delivery of First Embraer Praetor 600
30.11.2020 17:03:00 EET | Business Wire | Press release
Flexjet Ltd., offering travelers access to the world’s most luxurious fleet of private jets, accepted delivery of the first Praetor 600 aircraft in its European-based fleet, marking a significant milestone in the expansion of the company’s global business. Flexjet is the only shared-ownership/fractional provider of the Praetor 600, part of a US$1.4 billion order for Embraer Executive Jets, a division of Embraer S.A. (NYSE: ERJ; BM&FBOVESPA: EMBR3), that was announced in October 2019.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005564/en/
Flexjet Embraer Praetor 600 super midsized aircraft part of the European-based Flexjet fleet. (Photo: Business Wire)
European Managing Director Marine Eugène leads the team headquartered at Flexjet House in the Mayfair neighbourhood in the west end of London. In addition, Flexjet has opened facilities including a European Tactical Control Centre in the United Kingdom to coordinate flight logistics, an aircraft maintenance facility in Milan and Flexjet House, where an experience center envelops current and prospective Flexjet shared aircraft Owners.
“Flexjet has taken the time to lay the groundwork to properly serve those entering the shared aircraft ownership market in Europe,” said Eugène. “Now that we have the infrastructure in place, we are growing our fleet with the addition of our new Praetor 600 aircraft. The Praetor 600 will form part of our Red Label by Flexjet offering, bringing to European-based travelers a unique combination of innovative technology, luxury and premium service. Our objective is to give Owners the ability to travel not just in North America but throughout Europe, Africa and the Middle East without leaving the safety and security of the Flexjet family.”
Currently, only 110 shared-ownership aircraft are providing more than 800,000 flight hours per year in Europe. In contrast, there are nearly 700 private aircraft supporting 1.2 million flight hours annually in the U.S. With its growing presence in Europe, Flexjet intends to meet the needs of a European market, underserved by existing flight providers, offering the personalized levels of service, consistency and attention to detail for which Flexjet is known.
The Praetor 600 will be part of the premium Red Label by Flexjet programme. The only offering of its kind, Red Label by Flexjet features flight crews assigned to a single, specific aircraft, custom cabin interiors and the youngest fleet in the industry as well as innovations established in response to the COVID-19 pandemic.
Having the youngest fleet in the industry is just one of the ways that Flexjet is meeting the industrywide commitment to achieving its sustainability goals by 2050. To meet that target, Flexjet Ltd. has implemented a standard sustainability offering that goes far beyond carbon-neutral. All Owners’ flights will be fully emissions-neutral, compensating for carbon dioxide (CO2) emissions and also other non-carbon dioxide warming pollutants in aviation, such as water vapor, aerosol sulphate and nitrous oxides. This comprehensive programme requires offsetting an additional 300 percent on top of standard CO2 emissions, a truly innovative first in the sector.
As the fleet launch customer for the Praetor 600, Flexjet will add it to its existing European-based fleet of Embraer Legacy 500s and 600s. Announced by Embraer in 2018, the super-midsize Praetor 600 seats nine passengers plus a cabin server and offers class-leading capabilities that make it ideal for both business and leisure use. Its exceptional short-field performance enables it to fly into small airports – including London City (EGLC) – which reduces transit time both to businesses in city centers and to remote vacation locations. The Praetor 600 is the farthest-flying super-midsize jet in the world and has a range of more than 4,000 miles, making it easy to fly without stops from Paris to New York or London to Dubai.
In addition, the Praetor 600 is equipped with unparalleled high-speed satellite Wi-Fi connectivity and an industry-first touchscreen Upper Tech Panel that puts flight information and cabin controls at the passenger’s fingertips. In the cockpit, the Praetor 600 is the first super-midsize jet with full fly-by-wire technology, which powers the Active Turbulence Reduction that not only makes every flight the smoothest but also the most efficient possible. One of the distinctive features of the Praetor 600 is the enlarged winglets, roughly six feet high, which contribute to the aircraft’s fuel efficiency.
The aircraft air quality management system is comprehensive, with the ability to move 100 percent fresh air through the cabin and an additional HEPA filter that further improves air quality by filtering out 99.97 percent of all particles including bacteria, viruses and fungi. The Praetor 600 also has a cabin altitude of 5,800 feet when the aircraft is cruising at 45,000 feet. This pressure level, combined with higher humidity levels, means travellers will feel less fatigued and more active during the flight and better refreshed on arrival.
“With private jet service recovering much faster than commercial aviation in the wake of the COVID-19 pandemic, it’s clear that travelers want to minimize their risk of exposure to the coronavirus, and private jets are a lower-risk way to fly in the COVID-19 era. That makes this the perfect time to bring both the versatile Praetor 600 and the Red Label experience to the European market,” said Flexjet Chief Executive Officer Michael Silvestro. “With Marine Eugène at the helm, we look forward to the continued growth and evolution of our European offering.”
Michael Amalfitano, President & CEO, Embraer Executive Jets, added “Flexjet is the fleet launch customer for the Praetor aircraft, continuing a two-decade-long partnership with Embraer. We are pleased that Flexjet is introducing the world’s most technologically advanced super-midsized aircraft, the Praetor 600, to the European shared ownership market and has the capabilities to thoroughly disrupt the business aviation market. We are confident that Flexjet passengers here in Europe will enjoy the ultimate experience in business and private aviation.”
Flexjet continues to be a leader in safety and the well-being of its Owners. Flexjet was the first private jet provider to decontaminate its cabins with anti-microbial treatments (MicroShield 360 in U.S.-based aircraft and Bacoban ® on EU-based aircraft). Each Flexjet cabin also is equipped with MedAire’s Universal Precaution Kit containing tools to help protect both passengers and crew from possible exposure. Every Flexjet pilot or crewmember wears masks and receives a mandatory temperature check pre-tour and a second while on duty. In addition, each crewmember remains in compliance with WHO-recommended guidelines for social distancing both on the ground and in the air.
About Flexjet
Flexjet first entered the fractional jet ownership market in 1995. Flexjet offers fractional jet ownership and leasing. Flexjet’s fractional aircraft programme is the first in the world to be recognized as achieving the Air Charter Safety Foundation’s Industry Audit Standard, is the first and only company to be honored with 21 FAA Diamond Awards for Excellence, upholds an ARG/US Platinum Safety Rating and is IS-BAO compliant at Level 2. Flexjet’s fractional programme fields an exclusive array of business aircraft—some of the youngest in the fractional jet industry, with an average age of approximately six years. In 2015, Flexjet introduced Red Label by Flexjet, which features the youngest fleet in the industry, flight crews dedicated to a single aircraft and the LXi Cabin Collection of interiors. To date there are more than 40 different interior designs across its fleet, which includes the Embraer Phenom 300, Legacy 450 and Praetor 500, Bombardier Challenger 350, the Gulfstream G450, G500, G650 and G700, and the Aerion AS2 supersonic business jets. Flexjet’s European fleet includes the Embraer Praetor 600, Legacy 500 and 600. Flexjet is a member of the Directional Aviation family of companies. For more details on innovative programmes and flexible offerings, visit www.flexjet.com or follow us on Twitter @Flexjet and on Instagram @FlexjetLLC.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201130005564/en/
Contact information
Nicholas Parmelee
The Hubbell Group, Inc.
216-406-5602 (mobile)
781-878-8882 (office)
nparmelee@hubbellgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
